A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
Clinical trial NCT03745937 · COMPLETED
Trial details
- NCT number
- NCT03745937
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-05-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.